Read + Share
. Correction: Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban
Compared With Rivaroxaban and Effectiveness and Safety of Direct Oral
Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation. Ann Intern Med 2022;175:1627-1628.
PMID: 36375167
|
 |
|
